Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
about
Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine modelHepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.Akt1-mediated fast/glycolytic skeletal muscle growth attenuates renal damage in experimental kidney disease.New insight into the molecular drug target of diabetic nephropathy.Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertensionAlternative Interventions to Prevent Oxidative Damage following Ischemia/ReperfusionMadecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon.Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.Telmisartan/Hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patients.Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.The emerging role of hepatocyte growth factor in renal diseases.Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes.Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.Micro RNA-320 as a novel potential biomarker in renal ischemia reperfusion.Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.The potential signaling pathway between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha in renal interstitial fibrosis disease.Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways
P2860
Q28246398-78F3A077-4F14-4AED-861E-11B1954EEF31Q33669422-977343DE-59CF-4B5B-BD95-F0EB1AB3513AQ34068447-F3A0D32B-9827-417F-8F38-35E4A2BA44DEQ34568763-E94B3B49-FA2F-4D44-AAC2-49656EA57BC9Q35125585-45C22548-C3E8-474C-AAA0-831501469FF6Q36824736-EEF29924-0C6D-4D0F-A08B-9D43CD96C3EAQ37578724-6C07E13B-870C-42A1-9A32-547AA448C15FQ37686310-A2636BB9-7803-437D-8490-D16B539E71B4Q38087529-BD98A53D-EA35-42F4-B4DC-277C4AC34F58Q38111434-6C953220-1AC3-4B9F-97B5-85D92EEC0154Q38300981-8AD0481C-9671-480B-BCA0-4DB33BB761FCQ38605788-724E11EB-79FB-4078-A83E-92C901F0AA11Q39016280-30252320-D0D8-4A2D-BEF6-72A407265279Q39042046-1008EF03-9201-4F17-9B66-EF4C4D3F073AQ48111922-34813026-FB8C-40FD-B553-08EA49684E1BQ51734447-DA4DDDB3-467E-4608-B79B-0239F5071A2EQ52674866-1FFD7297-26BD-483E-8BEC-AABB17CE53B8Q53007399-EA38A4CA-E3F8-46B7-A2F3-F03BC5E88864Q58796043-639D8380-6830-4FBC-9518-B767CFFA5617
P2860
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Telmisartan exerts renoprotect ...... n II type 1 receptor blockade.
@en
Telmisartan exerts renoprotect ...... n II type 1 receptor blockade.
@nl
type
label
Telmisartan exerts renoprotect ...... n II type 1 receptor blockade.
@en
Telmisartan exerts renoprotect ...... n II type 1 receptor blockade.
@nl
prefLabel
Telmisartan exerts renoprotect ...... n II type 1 receptor blockade.
@en
Telmisartan exerts renoprotect ...... n II type 1 receptor blockade.
@nl
P2093
P1433
P1476
Telmisartan exerts renoprotect ...... n II type 1 receptor blockade.
@en
P2093
Fumihiro Sanada
Hiroshi Kusunoki
Junya Azuma
Kazuma Iekushi
Keita Okayama
Masaaki Iwabayashi
Ryuichi Morishita
Yoshiaki Taniyama
P304
P356
10.1161/HYPERTENSIONAHA.111.176263
P407
P577
2012-01-17T00:00:00Z